IDT offers rival bid to make 100 millions MRNA vaccines, page-122

IDT investors

especially newbies to the trading game. Are you wondering why the price is falling slightly and not 'rocketing' when the company is about to become an mRNA vaccine developer in Australia? Why isn't the big money buying it up to capitalize on these early day low prices etc?

Before I say anymore, we all know that IDT may become a very good investment and the big money may certainly enter. I too have made my modest entry buy.

But big brass has their reasons. If they were buying now, the price would be pushing much further than the measely 160m MC.

So why aren't they?

The answer is quite simple. It is not a sure thing yet, and big money doesn't flow until surety is secured - as far as it can be in stock trading. Speculation money will push it around a little, as it has done so far, but real gains won't occur until real money appears.

It is not a sure thing yet as their are other horses in the running, and it is in the reigns of politicians. Say no more.

Have you done your DD; have you read things like the following;

“The Thebarton facility, according to both Wisenberg and Anton Middelberg, professor of chemical and biomolecular engineering at Adelaide University, is the front-running bacterial cell plant in the country, and the only one with the right skillset and regulations already in place.‘When you look at mRNA vaccines, you actually need to have capacity to make bacterial fermentation work and do that in a regulated facility, and the only regulated facility in Australia at the moment, for bacterial fermentation, is BioCina,’ says Middelberg.”

If you havn't loooked into this single competitor, then you havn't done proper DD.

Do you DD before you invest too much. Eventually traders and investors learn that speculative investing requires being prepared for the unexpected. Don't become overly reliant on any 'sure thing' investment.